European Commission - Daily News
Brussels, 15 September 2016
The European Commission has approved under the EU Merger Regulation the acquisition of Anda Distribution of the US by Teva Pharmaceutical Industries Limited of Israel.
Anda is a distributor of pharmaceutical products, serving pharmacies, nursing homes, hospitals and clinics in the US only. Teva is active worldwide in the development, manufacturing, marketing, sale and distribution of pharmaceutical products, biopharmaceuticals and pharmaceutical ingredients.
The Commission concluded that the proposed acquisition would raise no competition concerns because there are no overlaps between the companies' activities, and Anda does not generate any revenue in the European Economic Area. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.8193.
(For more information: Ricardo Cardoso – Tel.: +32 229 80100; Angela Nardella- Tel.: +32 229 86801)
Source: Europa.eu (Copyright European Commission)